Recent Tech Transfer Deals (04/2008)
This article was originally published in Start Up
Executive Summary
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
You may also be interested in...
Coppertone Sunscreen 'Pure & Simple'? Class Action Plaintiff Begs To Differ
Plaintiff Mark Ballotti alleges that 17 of 24 ingredients in Coppertone Pure & Simple SPF 50 Mineral Lotion are neither pure nor simple, “because they are made by mixing with other substances and materials and significantly modified,” in his complaint filed in Illinois’ Northern District.
Gilead And Arcus’ Latest Update Keeps TIGIT Hopes Afloat
Gilead and Arcus believe their ‘Fc silent’ TIGIT inhibitor candidate could be best in class, but analysts think only outstanding results in lung cancer will sway investor sentiment.
AstraZeneca Takes Personalized Approach To Cell Therapy With Neogene Buy
The UK major has been building its cell therapy portfolio for about three years internally, oncology R&D chief Susan Galbraith tells Scrip, and the purchase of Neogene and its TCR-Ts targeting neoantigens in solid cancers is a logical step.